SCHEMBL30965462

SCHEMBL30965462

O=C(Nc1ccccc1)Nc1ccc(Oc2ccccc2)c(Cn2cncn2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MCHR1 Q99705 4/20 0.41
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
IMPDH2 P12268 1/20 0.40
KDR P35968 2/20 0.40
TNNI3K Q59H18 1/20 0.40
NAMPT P43490 1/20 0.40
HIF1A Q16665 1/20 0.40
MCHR2 Q969V1 1/20 0.40
PDGFRA P16234 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24065505 1.00 RAF1 (0.42) RAF1SMN1; SMN2CA12CA1CA2
SCHEMBL30965478 0.84 MAPT (0.52) RAF1SMN1; SMN2CA12CA1CA2
SCHEMBL24065475 0.84 MAPT (0.52) RAF1SMN1; SMN2CA12CA1CA2
SCHEMBL30965496 0.82 CYP19A1 (0.61) RAF1NPC1IMPDH2CYP19A1
SCHEMBL23292615 0.82 CYP19A1 (0.61) RAF1NPC1IMPDH2CYP19A1
SCHEMBL23292626 0.78 NPC1 (0.51) RAF1SMN1; SMN2CA12CA1CA2
SCHEMBL21305508 0.78 NPC1 (0.54) RAF1SMN1; SMN2CA12CA1CA2
SCHEMBL24065504 0.77 KDM4E (0.47) SMN1; SMN2KDM4EALDH1A1NPC1MAPT
SCHEMBL30965508 0.77 KDM4E (0.47) SMN1; SMN2KDM4EALDH1A1NPC1MAPT
SCHEMBL23292656 0.77 NPC1 (0.50) SMN1; SMN2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112513032-B 4-Substituted phenyl-1, 3, 5-triazine derivatives as modulators of TRK receptors 阿泽克制药公司 2024-07-02 CN disclosed